Heavy bureaucracy, but large structure to grow/move in - Avis employé Senior IT Business Analyst Genentech

5,0
27 févr. 2025
Recommande
Approbation du PDG
Perspective commerciale

Avantages

- Large corporation made of many different groups (learning and movement opportunity) - Innovation is driven through competition between groups - Amazing campus and brilliant minds - Great company culture

Inconvénients

- Bureaucracy and ability to defend technology/value proposition of the group is key - Internal competition is stiff; it's difficult to get in as personnel is constantly moving - Outlook of product development pipeline

Découvrez plus d’avis sur Genentech

5,0
1 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Extremely experience team members and supportive corporate structure enables the field teams to execute on national strategy

Inconvénients

The bonus structure can be a bit political

3,0
7 mai 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Genentech's origin story and mission are genuinely inspiring — few companies can point to such a meaningful historical arc in medicine. Patient engagement is taken seriously and feels authentic, not performative. The campus is beautiful and the culture has real warmth.

Inconvénients

DDA is operating with significant gaps. First, the foundational data infrastructure is not mature enough to support the ambitions being set for the team. Second, the measurement culture has gotten ahead of the methodology, and no one in a position of authority seems to be asking hard questions about whether the numbers actually mean what they're being presented as meaning. Third, some management feel disconnected from the work itself, lacking the knowledge, hands-on experience, or relevant credentials. Individually any one of these would be manageable. Together these create an environment where it's hard to do rigorous work, rather work is performative, and be recognized for it.

1
Voir les avis par: Utile|Évaluation|Date|Tout